55134-51-5 (4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid,alpha-Tocopherol succinate)

结构式：

4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acidMOL文件

CAS号：

55134-51-5

中文名称：

4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid

英文名称：

alpha-Tocopherol succinate

分子式：

C₃₃H₅₄O₅

分子量：

530.778871059418

4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid(55134-51-5)名称与标识符

名称

中文别名：

4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid;

英文别名：

alpha-Tocopheryl hydrogen succinate;TOCOPHERYL ACID SUCCINATE,D-ALPHA [VANDF];4-Oxo-4-(((R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)oxy)butanoic acid;DB14001;D- alpha -Tocopheryl Succinate;D-alpha-Tocopherol succinate, analytical standard;VITAMIN E (ALPHA-TOCOPHERYL SUCCINATE);Succinic acid, mono(2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chromanyl) ester, (+)-;Butanedioic acid, mono[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl] ester, [2R-[2R*(4R*,8R*)]]-;.alpha.-tocopheryl succinate, d-;Butanedioic acid, mono[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl] ester;A-Tocopherol succinate;RRR-alpha-Tocopheryl Hydrogen Succinate;D-alpha-Tocopherol succinate, semisynthetic, 1210 IU/g;Tox21_112556;17407-37-3;RRR-ALPHA-TOCOPHERYL HYDROGEN SUCCINATE (EP IMPURITY);Butanedioic acid, 1-((2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl) ester;(+)-alpha-Tocopheryl succinate;55134-51-5;alpha-Tocopheryl succinate, D-;EINECS 241-433-7;Q27283185;d-alpha-Tocopherol acid succinate;T2628;2,5,7,8-Tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chromanyl hydrogen succinate, (+)-;Covitol 1210;NS00045903;CCG-207945;4-oxo-4-(((2R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl)oxy)butanoic acid;CCRIS 4734;NCGC00258122-01;d-a-tocopherol succinate;alpha-Tocopherol acid succinate, D-;Alpha-tocopherol succinate, d-;DTXCID706151;AC-1132;(+)-.alpha.-Tocopherol acid succinate;alpha tocopheryl acid succinate;RRR-.ALPHA.-TOCOPHERYL HYDROGEN SUCCINATE;CS-0136520;Tocopheryl Acid Succinate, a, Pharmaceutical Secondary Standard; Certified Reference Material;NSC173849;alpha-Vitamin E succinate;Butanedioic acid, mono[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl] ester;D-?-Tocopherol succinate;AS-75106;RRR-alpha-Tocopheryl hydrogen succinate; (2R)-2,5,7,8-Tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-yl hydrogen succinate; d-alpha-tocopherol succinate; Vitamin E succinate; (+)-alpha-tocopheryl acid succinate; D-alpha-Tocopheryl hydrogen succinate;D-.alpha.-Tocopheryl succinate;TOCOPHERYL ACID SUCCINATE [WHO-DD];D-alpha-Tocopherol succinate;Butanedioic acid, mono(3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl) ester;(+)-alpha-Tocopherol acid succinate;4-Oxo-4-(((R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl)oxy)butanoicacid;CHEBI:135821;3-{[(2R)-2-((4R,8R)-4,8,12-trimethyltridecyl)-2,5,7,8-tetramethylchroman-6-yl] oxycarbonyl}propanoic acid;White-e [veterinary] (TN);EINECS 224-403-8;TOCOPHERYL ACID SUCCINATE,D-ALPHA;UNII-LU4B53JYVE;AKOS015902063;HY-131553;Dal-Vita brand of vitamin E succinate;EN300-23011947;.alpha.-tocopheryl succinate;Tocopherol acid succinate, alpha-;a-Tocopheryl Succinate;4-oxo-4-((R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yloxy)butanoic acid;alpha-Tocopherol hemisuccinate;6-Chromanol, 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, hydrogen succinate, (+)-;RRR-ALPHA-TOCOPHERYL ACID SUCCINATE;TOCOPHERYL SUCCINATE [INCI];RRR-alpha-Tocopheryl hydrogen succinate, European Pharmacopoeia (EP) Reference Standard;vitamin e succinate;Butanedioic acid,mono[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl] ester;4-oxo-4-[[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid;J24.824J;RRR-ALPHA-TOCOPHERYL ACID SUCCINATE [FCC];NCGC00167561-01;Butanedioic acid, mono(3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl) ester, (2R-(2R*(4R*,8R*)))-;RRR-.ALPHA.-TOCOPHERYL HYDROGEN SUCCINATE [EP IMPURITY];NCGC00167561-03;Butanedioic acid, 1-[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl] ester;C033716;D-alpha-Tocopherol succinate, BioXtra, >=98.0% (HPLC);4345-03-3;Vitamin-E Dragees;alpha-Tocopheryl succinate;.ALPHA.-TOCOPHEROL SUCCINATE, D-;White-e (veterinary);mono((2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl) butanedioate;D-.alpha.-Tocopherol succinate;SCHEMBL134422;MFCD00072055;D-ALPHA-TOCOPHERYL SUCCINATE;Wiedemann brand of vitamin E succinate;CV 104;LU4B53JYVE;Tocopheryl Acid Succinate, d-Alpha;4-oxo-4-{[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-yl]oxy}butanoic acid;Vitamine E succinate;alpha-Tocopheryl acid succinate;.alpha.-Tocopherol succinate;Tox21_200568;SR-01000883728;Alpha tocopheryl acid succinate, United States Pharmacopeia (USP) Reference Standard;Butanedioic acid, mono((2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl) ester;NSC-173849;4-oxo-4-[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]chroman-6-yl]oxy-butanoic acid;NCGC00167561-02;SR-01000883728-1;alpha-Tocopherol, succinate, D-;Mono(3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl) butanedioate, (2R-(2R*(4R*,8R*)))-;alpha-Tocopherol, succinate;D-ALPHA TOCOFERIL ACID SUCCINATE (MART.);D-;D-alpha-tocopheryl-succinate;D-ALPHA TOCOFERIL ACID SUCCINATE [MART.];D08612;alpha-tocopherol succinate;TOCOPHERYL ACID SUCCINATE [VANDF];BRD-K64636206-001-02-7;DTXSID2026151;Mono(2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chromanyl) succinate, (+)-;BDBM50458511;CAS-4345-03-3;Dal-E;C90299;tocopherol succinate;D-alpha-Tocopheryl hydrogen succinate;Tocopheryl succinate;Z2216889767;.ALPHA.-TOCOPHEROL SUCCINATE [MI];Vitamin E hemisuccinate;CHEMBL81421;(3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl) hydrogen succinate;SBI-0636756.0001;D-alpha tocopheryl acid succinate;NSC 173849;

标识符

InChIKey：

IELOKBJPULMYRW-NJQVLOCASA-N

Inchi：

1S/C33H54O5/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-20-33(8)21-19-28-27(7)31(25(5)26(6)32(28)38-33)37-30(36)18-17-29(34)35/h22-24H,9-21H2,1-8H3,(H,34,35)/t23-,24-,33-/m1/s1

SMILES：

O1C2C(C)=C(C)C(=C(C)C=2CC[C@@]1(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)OC(CCC(=O)O)=O

4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid(55134-51-5)物化性质

计算特性

精确分子量 : 530.39712482Da
氢键供体数量 : 1
氢键受体数量 : 5
可旋转化学键数量 : 17
同位素质量 : 530.39712482Da
重原子数量 : 38
复杂度 : 720
同位素原子数量 : 0
确定原子立构中心数量 : 3
不确定原子立构中心数量 : 0
确定化学键立构中心数量 : 0
不确定化学键立构中心数量 : 0
共价键单元数量 : 1
疏水参数计算参考值（XlogP） : 10.2
拓扑分子极性表面积 : 72.8Å²

4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid(55134-51-5)相关文献

1. Nanoparticle mediated alteration of EMT dynamics: an approach to modulate cancer therapeutics
Plaboni Sen,Muktashree Saha,Siddhartha Sankar Ghosh Mater. Adv. 2020 1 2614
2. Multifunctional dendrimers modified with alpha-tocopheryl succinate for targeted cancer therapy
Yun Zheng,Fanfan Fu,Mengen Zhang,Mingwu Shen,Meifang Zhu,Xiangyang Shi Med. Chem. Commun. 2014 5 879
3. Engineered vitamin E-tethered non-immunogenic facial lipopeptide for developing improved siRNA based combination therapy against metastatic breast cancer
Argha Mario Mallick,Abhijit Biswas,Sukumar Mishra,Sonali Jadhav,Kasturee Chakraborty,Archana Tripathi,Arnab Mukherjee,Rituparna Sinha Roy Chem. Sci. 2023 14 7842
4. The determination of vitamin E in food by colorimetry and gas-liquid chromatography
A. A. Christie,Anne C. Dean,Barbara A. Millburn Analyst 1973 98 161
5. d-α-Tocopheryl polyethylene glycol 1000 succinate conjugated folic acid nanomicelles: towards enhanced bioavailability, stability, safety, prolonged drug release and synergized anticancer effect of plumbagin
Atmaram Pawar,Rabiya Patel,S. Arulmozhi,C. Bothiraja RSC Adv. 2016 6 78106
6. RTG-loaded nanomicelles (CS–VES–NAC) for oral anti-HIV drug delivery
Liming Hu,Jiazhou Wu,Zhipeng Li,Ming Bu,Shenglin Qiao,Hao Wang RSC Adv. 2016 6 75890
7. Enhanced therapeutic efficacy and cytotoxicity of doxorubicin-loaded vitamin E – Pluronic micelles against liver cancer
Y. J. Li,M. Dong,F. M. Kong,J. P. Zhou RSC Adv. 2015 5 43965
8. In vivo and in vitro evaluation of dihydroartemisinin prodrug nanocomplexes as a nano-drug delivery system: characterization, pharmacokinetics and pharmacodynamics
Guolian Ren,Pei Chen,Jiaqi Tang,Wenju Guo,Rongrong Wang,Ning Li,Yujie Li,Guoshun Zhang,Ruili Wang,Shuqiu Zhang RSC Adv. 2020 10 17270
9. Encapsulation of enzymes in metal ion–surfactant nanocomposites for catalysis in highly polar solvents
Xun Cao,Yan Ni,Alei Zhang,Sheng Xu,Kequan Chen,Pingkai Ouyang Chem. Commun. 2017 53 3134
10. Turn up the cellular power generator with vitamin E analogue formulation
Ru Wen,Shanta Dhar Chem. Sci. 2016 7 5559

810668-53-2(Methyl (4Z,7S,8E,10Z,12E,14E,16R,17S,19Z)-7,16,17-trihydroxy-4,8, 10,12,14,19-docosahexaenoate) 81115-49-3(6-羧酸-5-氨基-1H-吲唑) 80880-90-6(替仑西平) 812640-83-8((1-(PYRIDIN-2-YL)CYCLOPROPYL)METHANAMINE) 81324-61-0(3-溴-4-甲氧基苯甲酰氯) 80650-47-1(2-chloro-N-(4,5-dihydro-1,3-thiazol-2-yl)acetamide) 809231-57-0(L-2-(BOC-AMINO)-3-(4'-METHOXYBIPHENYL-4-YL)PROPANOIC ACID) 811431-33-1(1-(6-氨基-9H-嘌呤-9-基)-1,5-二脱氧-2,3-O-(1-甲基亚乙基)-BETA-D-呋喃核己糖醛酸)

960化工网为您提供4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid专业化合物百科信息，包括中文名，英文名，分子式，分子量，以及该化合物的CasNo.55134-51-5,相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等。 WAP版:55134-51-5 国际站:55134-51-5

55134-51-5 (4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid,alpha-Tocopherol succinate)

4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid(55134-51-5)名称与标识符

名称

标识符

4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid(55134-51-5)物化性质

计算特性

4-Oxo-4-({(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltri decyl]-3,4-dihydro-2H-chromen-6-yl}oxy)butanoic acid(55134-51-5)相关文献

目录